February 22. – 25. #ATTD2023 took place in Berlin, Europe. At the16th International Conference on Advanced Technologies & Treatments for Diabetes the HCPs from all over the world learned about innovation in diabetes medicines and treatments, the most cutting-edge technologies, and the latest research.
For the 4th time #dedoc voices around the globe had access to all the content of the conference. In presence and virtually. 50 voices from the field of advocacy with the strong presence on social media and in the Diabetes Online Community, the most of them, people living with diabetes themselves and the caregivers. To take advantage of the value diabetes advocates bring to the scientific congresses is possible thanks to #dedoc voices scholarship program. Learn more about program here.
Transparency & Desiclosure Statement
I am a part of #dedoc voices program, an initiative of #dedoc. #dedoc has granted me complimentary registration to the conference. Part of being one of #dedoc voices is to share what I learn with the diabetes community. Everything I share is in my own words.
Find out all ATTD 2023 #dedoc voices and connect with them here:
- Australia
- Canada
- Egypt
- Germany
- Guatemala
- India
- Ireland
- Nothern Ireland
- Italy
- Italy & Slovakia
- Mexico
- Pakistan
- Poland
- Portugal
- Romania
- Saudi Arabia
- Asra Ahmed – Facebook
- Slovakia (*see Italy & Slovakia)
- South Africa
- Spain
- Scotland
- Switzerland
- The Netherlands
- Uganda
- United Kingdom
- United States
- Uruguay
- Zimbabwe
We would like to thank ATTD & the Kenes Group for welcoming the #dedoc° voices to their conference, as well as our sponsors Lilly, Dexcom, Diabeloop, Medtronic, Sanofi and dot.COOL for making this scholarship program possible.
The next call for applications for EASD & ISPAD 2023 will be launched in July 2023.
👈Read about Multistakeholders meeting held in Berlin just before #ATTD2023
#type1dmaniac 